| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Miranda Adrian | CMO, SVP Science & Tech | 11611 N. MERIDIAN ST,, SUITE 330, CARMEL | /s/ Adrian Miranda | 02 Mar 2026 | 0001992525 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NRXS | RSU | Award | $220,244 | +47,569 | $4.63 | 47,569 | 22 Jan 2026 | Common Stock | 47,569 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | These shares of common stock are restricted stock units (RSUs) granted to the reporting person as compensation under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs vest in three equal annual installments over a three-year period. |